Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
S&P Global
SPGI
|
$677M |
| 2 |
AGN
Allergan plc
AGN
|
$438M |
| 3 |
lululemon athletica
LULU
|
$407M |
| 4 |
Qualcomm
QCOM
|
$393M |
| 5 |
NVIDIA
NVDA
|
$376M |
Top Sells
| 1 |
Under Armour
UAA
|
$1.04B |
| 2 |
Abbott
ABT
|
$758M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
$627M |
| 4 |
Meta Platforms (Facebook)
META
|
$516M |
| 5 |
MON
Monsanto Co
MON
|
$453M |
Sector Composition
| 1 | Consumer Discretionary | 19.2% |
| 2 | Healthcare | 16.74% |
| 3 | Technology | 15.05% |
| 4 | Communication Services | 12.7% |
| 5 | Financials | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Flowserve
FLS
$7.22B
| – | – |
-603,382
| Closed | -$26.8M |
|
627
Gilead Sciences
GILD
$143B
| – | – |
-9,147
| Closed | -$840K |
|
628
General Mills
GIS
$27B
| – | – |
-48,830
| Closed | -$3.09M |
|
629
Globus Medical
GMED
$8.18B
| – | – |
-9,780
| Closed | -$232K |
|
630
Group 1 Automotive
GPI
$6.26B
| – | – |
-10,917
| Closed | -$641K |
|
631
HealthEquity
HQY
$7.88B
| – | – |
-21,659
| Closed | -$534K |
|
632
Herc Holdings
HRI
$4.6B
| – | – |
-2,484,271
| Closed | -$78.5M |
|
633
iShares Biotechnology ETF
IBB
$5.8B
| – | – |
0
| – | – |
|
634
IBM
IBM
$232B
| – | – |
-14,853
| Closed | -$2.15M |
|
635
iShares Russell 2000 ETF
IWM
$67.8B
| – | – |
0
| – | – |
|
636
iShares US Healthcare ETF
IYH
$2.77B
| – | – |
0
| – | – |
|
637
LendingClub
LC
$1.9B
| – | – |
-164,018
| Closed | -$6.81M |
|
638
Lear
LEA
$5.91B
| – | – |
-477,988
| Closed | -$53.1M |
|
639
Macy's
M
$4.64B
| – | – |
-1,371,063
| Closed | -$60.5M |
|
640
Marsh & McLennan
MMC
$100B
| – | – |
-36,694
| Closed | -$2.23M |
|
641
Match Group
MTCH
$9.18B
| – | – |
-991,089
| Closed | -$11M |
|
642
Oracle
ORCL
$654B
| – | – |
-44,417
| Closed | -$1.82M |
|
643
Pacira BioSciences
PCRX
$1.19B
| – | – |
-954,110
| Closed | -$50.5M |
|
644
Post Holdings
POST
$5.88B
| – | – |
-8,777
| Closed | -$395K |
|
645
Qualys
QLYS
$4.87B
| – | – |
-138,894
| Closed | -$3.52M |
|
646
RH
RH
$4.7B
| – | – |
-21,305
| Closed | -$893K |
|
647
SCYNEXIS
SCYX
$37.3M
| – | – |
-32,078
| Closed | -$1.29M |
|
648
Steven Madden
SHOO
$2.2B
| – | – |
-13,445
| Closed | -$332K |
|
649
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
|
WBA
650
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-17,826
| Closed | -$1.5M |
|